Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; Diabetes Glycaemic Education and Monitoring Trial Group.

BMJ. 2008 May 24;336(7654):1177-80. doi: 10.1136/bmj.39526.674873.BE. Epub 2008 Apr 17.

2.

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.

3.

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060. doi: 10.1002/14651858.CD005060.pub3. Review.

PMID:
22258959
4.

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.

Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A.

BMJ. 2007 Jul 21;335(7611):132. Epub 2007 Jun 25.

5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
6.

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin.

Cameron C, Coyle D, Ur E, Klarenbach S.

CMAJ. 2010 Jan 12;182(1):28-34. doi: 10.1503/cmaj.090765. Epub 2009 Dec 21.

8.

Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.

O'Kane MJ, Bunting B, Copeland M, Coates VE; ESMON study group.

BMJ. 2008 May 24;336(7654):1174-7. doi: 10.1136/bmj.39534.571644.BE. Epub 2008 Apr 17.

9.

Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.

Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC, Davies MJ.

BMJ. 2010 Aug 20;341:c4093. doi: 10.1136/bmj.c4093.

10.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

11.

Self-monitoring of blood glucose in type 2 diabetes: systematic review.

Clar C, Barnard K, Cummins E, Royle P, Waugh N; Aberdeen Health Technology Assessment Group.

Health Technol Assess. 2010 Mar;14(12):1-140. doi: 10.3310/hta14120. Review.

12.
13.

Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol.

Dallosso HM, Eborall HC, Daly H, Martin-Stacey L, Speight J, Realf K, Carey ME, Campbell MJ, Dixon S, Khunti K, Davies MJ, Heller S.

BMC Fam Pract. 2012 Mar 14;13:18. doi: 10.1186/1471-2296-13-18.

15.

A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study.

Ismail K, Maissi E, Thomas S, Chalder T, Schmidt U, Bartlett J, Patel A, Dickens C, Creed F, Treasure J.

Health Technol Assess. 2010 May;14(22):1-101, iii-iv. doi: 10.3310/hta14220.

16.
17.

A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE).

Newman SP, Cooke D, Casbard A, Walker S, Meredith S, Nunn A, Steed L, Manca A, Sculpher M, Barnard M, Kerr D, Weaver J, Ahlquist J, Hurel SJ.

Health Technol Assess. 2009 May;13(28):iii-iv, ix-xi, 1-194. doi: 10.3310/hta13280.

18.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

19.

Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial.

French DP, Wade AN, Yudkin P, Neil HA, Kinmonth AL, Farmer AJ.

Diabet Med. 2008 Oct;25(10):1218-28. doi: 10.1111/j.1464-5491.2008.02569.x.

PMID:
19046201
20.

Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.

Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S, Nicholl JP.

Health Technol Assess. 2005 Aug;9(32):iii-iv, ix-x, 1-109.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk